Editor Brian Harrod Provides Comprehensive up-to-date news coverage, with aggregated news from sources all over the world from the Roundup Newswires Network
EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company for use by severe allergy sufferers are seen in Washington, U.S. August 24, 2016. Mylan NL Chief Executive Officer Heather Bresch will appear at a Sept.
Sado-masochism has evidently become the fashion in the pharmaceutical industry. A case in point is Mylan's decision to raise the price of their EpiPen to $600.
Mylan NV's latest attempt to deflect criticism over the price of allergy shot EpiPen failed to get the drugmaker out of the sights of Congress. Last week, Chief Executive Officer Heather Bresch was quick to react to the mounting political scrutiny over EpiPen's price hike with measures to reduce patients' out-of-pocket costs for the shot's $600 brand-name version.
Give Hillary Clinton credit for calling out Mylan NV for price-gouging on its Epi-Pen emergency allergy shot. While a bipartisan group of U.S. Senators initially raised a ruckus over the drug's 400 percent cost increase, it was Clinton's voice that brought pressure to bear on the company to reduce prices.
The controversy surrounding the skyrocketing costs of Mylan's EpiPens, medication that counteracts potentially deadly allergic reactions, is "a product of their own success," according to a Wall Street Journal reporter on the pharma beat. "For a long time, this wasn't a product that many people knew about or wanted and it's really a credit to Mylan for making it into a brand with a name that is as well-recognized and highly sought as Band-Aids," Jonathan Rockoff said on Friday's MetroNews "Talkline."
The mounting congressional scrutiny of pharmaceutical giant Mylan over its 400 percent price hike for EpiPen has created an awkward situation on Capitol Hill for Democratic Sen. Joe Manchin -- his daughter runs the company at the center of the scandal. Colleagues on both sides of the aisle, as well as Democratic presidential candidate Hillary Clinton, are now slamming Mylan and demanding investigations into why prices were jacked so high on the lifesaving allergy treatment drug.
Heather Bresch, the Mylan CEO under fire for skyrocketing EpiPen costs, believes Americans should redirect their anger toward a "broken" health care system. Mylan was forced to respond to the national outrage over a more than 400% increase in price for the lifesaving allergy treatment by pledging on Thursday to make it more affordable.
Mylan Pharmaceuticals said Thursday that it would be giving a $300 "savings card" discount for a two-pack of EpiPens amid pressure to cut the price of the drug. Mylan has increased the price of EpiPen by 500% since it acquired the drug in 2007, and it didn't budge on the actual list price of the drug.
Drug maker Mylan said Thursday that it would offer discounts on a life-saving allergy shot after generating a firestorm when it implemented sharp price increases for the treatment. EpiPen maker to offer discounts after price hike firestorm Drug maker Mylan said Thursday that it would offer discounts on a life-saving allergy shot after generating a firestorm when it implemented sharp price increases for the treatment.
U.S. Sen. Joe Manchin remained mum Wednesday as a pharmaceutical company run by his daughter faced mounting criticism for hiking prices on life-saving allergy injection pens. The Democratic West Virginia senator's daughter, Heather Bresch , is CEO of Mylan, the manufacturer of EpiPens.
Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.
Watch Interview With Kansas City Fed President Esther George on Mornings with Maria on Fox Business at 7:30 ET Just about a year after Democratic presidential nominee sent biotechnology stocks and exchange traded funds tumbling with rhetoric aimed at high drug prices, one would think that any healthcare company and its executives opting to raise prices on devices, pharmaceuticals and treatments by hundreds of a percent is just asking for trouble. Well, Mylan NV can now be a case study in bungling executive leadership after revealing steep price increases for its EpiPen used to treat patients with severe allergic reactions.
U.S. Sen. Joe Manchin remained mum Wednesday as a pharmaceutical company run by his daughter faced mounting criticism for hiking prices on life-saving allergy injection pens. The Democratic West Virginia senator's daughter, Heather Bresch, is CEO of Mylan, the manufacturer of EpiPens.
Walker County has filed a notice of appeal to the 11th Circuit Court of Appeals on the ruling by Federal Judge Harold Murphy that the county pay Erlanger Health System over $8 million related to the Hutcheson Hospital bankruptcy.
U.S. Sen. Amy Klobuchar speaks about price hikes for EpiPens, the emergency drug injectors for severe allergic reactions, at Children's Hospital on Wednesday, Aug. 24, 2016, in Minneapolis. Klobuchar, a Minnesota Democrat who has worked to contain prescription drug price increases and whose 21-year-old daughter carries an EpiPen because of severe nut allergies, is one of several members of Congress demanding more information on why EpiPen prices have soared less U.S. Sen. Amy Klobuchar speaks about price hikes for EpiPens, the emergency drug injectors for severe allergic reactions, at Children's Hospital on Wednesday, Aug. 24, 2016, in Minneapolis.
Jackson Laboratory in Bar Harbor will receive nearly $12 million in federal money to pay for its new center that will study drug addiction. The lab's new facility will be called the Center for System Neurogenetics of Addiction .
After a successful trial in rhesus monkeys, a team of researchers, including doctors from Boston's Beth Israel Deaconess Medical Center, is ready to start testing a Zika virus vaccine in humans, they announced this week.
Florida Gov. Rick Scott speaks at a press conference about the Zika virus as Centers for Disease Control and Prevention director Dr. Tom Frieden , Congresswoman Frederica Wilson and Florida Surgeon General Celeste Philip look on in Doral, Florida, U.S. on August 4, 2016. REUTERS/Joe Skipper/File Photo Florida Republican Governor Rick Scott on Sunday accused the federal government of lagging in providing assistance to combat the spread of the Zika virus in a Miami-area neighborhood, the site of the first U.S. transmission of the virus.
President Barack Obama's administration warned Congress on Wednesday that money to fight the Zika virus is on the verge of running out as Capitol Hill faces a political stalemate. In a letter to key lawmakers, the secretary of Health and Human Services said the National Institutes of Health would exhaust its resources for vaccine development by month's end.